0
Skip to Content
No Patient Left Behind
About Us
What We Believe
Who We Are
Our Team
Advisory Councils
Life Science Builders
Policy
Value of Medicines
Protect Innovation
Fix Insurance
Most Favored Nation
All Letters
Learn
Fundamentals
Biotech Unveiled
Call the Inventors
Featured Materials
Resource library
chat-NPLB
Webinar Series: The Fine Print
Get Involved
NPLB Fellowship
Patient Stories
Become a First Responder
Community Quests
News
Press releases
Media
Blog
Search
Donate
No Patient Left Behind
About Us
What We Believe
Who We Are
Our Team
Advisory Councils
Life Science Builders
Policy
Value of Medicines
Protect Innovation
Fix Insurance
Most Favored Nation
All Letters
Learn
Fundamentals
Biotech Unveiled
Call the Inventors
Featured Materials
Resource library
chat-NPLB
Webinar Series: The Fine Print
Get Involved
NPLB Fellowship
Patient Stories
Become a First Responder
Community Quests
News
Press releases
Media
Blog
Search
Donate
Folder: About Us
Back
What We Believe
Who We Are
Our Team
Advisory Councils
Life Science Builders
Folder: Policy
Back
Value of Medicines
Protect Innovation
Fix Insurance
Most Favored Nation
All Letters
Folder: Learn
Back
Fundamentals
Biotech Unveiled
Call the Inventors
Featured Materials
Resource library
chat-NPLB
Webinar Series: The Fine Print
Folder: Get Involved
Back
NPLB Fellowship
Patient Stories
Become a First Responder
Community Quests
Folder: News
Back
Press releases
Media
Blog
Search
Donate
Featured
8 Ways to Modernize the FDA
Aug 21, 2025
8 Ways to Modernize the FDA
Aug 21, 2025

Our modern world needs a modern Food and Drug Administration (FDA). As PDUFA VIII offers a historic opportunity to make the drug review program faster, more consistent, and more transparent, here are a few suggestions we heard from our network of experts.

Read More →
Aug 21, 2025
5 ways Biden’s SOTU could advance biotech affordability and innovation
Mar 5, 2024
5 ways Biden’s SOTU could advance biotech affordability and innovation
Mar 5, 2024

Here are five policies President Biden should include in his State of the Union address on Thursday.

Read More →
Mar 5, 2024
Measuring the damage: IRA’s impact on small molecule drug development
Mar 31, 2023
Measuring the damage: IRA’s impact on small molecule drug development
Mar 31, 2023

Read what one oncology executive discovered when he surveyed the biotech community.

Read More →
Mar 31, 2023
PBMs: The Secretive Middlemen for Insurance and Drug Companies
Dec 25, 2020
PBMs: The Secretive Middlemen for Insurance and Drug Companies
Dec 25, 2020
Read More →
Dec 25, 2020

About Us

What We Believe
Who We Are
Our Team
Advisory Councils

Policy

Value of Medicines (GCEA)
Small Molecule Parity
Fixing Insurance

Resources

Presentations
Animations & Videos
Research
Advocacy

In the News

Press Releases
Media Coverage
Blog


Copyright, No Patient Left Behind 2023 | A Mission Edge Project

Privacy Policy
Cookie Policy
/* Autoscroll fix */